CytoSorbents Corp. (CTSO)
0.36
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
0.36
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Shareholders Equity (Quarterly) : -0.751M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.751M |
| March 31, 2026 | 2.194M |
| December 31, 2025 | 5.903M |
| September 30, 2025 | 9.02M |
| June 30, 2025 | 11.59M |
| March 31, 2025 | 14.54M |
| December 31, 2024 | 11.11M |
| September 30, 2024 | 13.00M |
| June 30, 2024 | 16.74M |
| March 31, 2024 | 18.93M |
| December 31, 2023 | 23.48M |
| September 30, 2023 | 18.51M |
| June 30, 2023 | 24.09M |
| March 31, 2023 | 28.96M |
| December 31, 2022 | 35.38M |
| September 30, 2022 | 39.14M |
| June 30, 2022 | 47.56M |
| March 31, 2022 | 55.43M |
| December 31, 2021 | 62.58M |
| September 30, 2021 | 70.61M |
| June 30, 2021 | 74.38M |
| March 31, 2021 | 77.26M |
| December 31, 2020 | 79.22M |
| September 30, 2020 | 80.23M |
| June 30, 2020 | 24.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.31M |
| December 31, 2019 | 3.418M |
| September 30, 2019 | 6.734M |
| June 30, 2019 | 11.54M |
| March 31, 2019 | 15.01M |
| December 31, 2018 | 16.93M |
| September 30, 2018 | 20.07M |
| June 30, 2018 | 21.56M |
| March 31, 2018 | 14.45M |
| December 31, 2017 | 10.26M |
| September 30, 2017 | 9.474M |
| June 30, 2017 | 7.916M |
| March 31, 2017 | -1.571M |
| December 31, 2016 | 1.338M |
| September 30, 2016 | 1.379M |
| June 30, 2016 | 3.897M |
| March 31, 2016 | 6.264M |
| December 31, 2015 | 8.211M |
| September 30, 2015 | 9.356M |
| June 30, 2015 | 11.57M |
| March 31, 2015 | 9.666M |
| December 31, 2014 | 3.963M |
| September 30, 2014 | -10.80M |
| June 30, 2014 | 8.488M |
| March 31, 2014 | -7.259M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.96M |
| Total Liabilities (Quarterly) | 38.71M |
| Debt to Equity Ratio | -39.93 |
| Current Ratio | 0.6551 |
| Net Debt Paydown Yield | -2.34% |